Priming of cancer-immunity cycle by alleviating hypoxia-induced ferroptosis resistance and immunosuppression
Stimulating a robust cancer-immunity cycle (CIC) holds promising potential for eliciting potent and enduring immune responses for cancer immunotherapy. However, designing a therapeutic nanomaterial capable of both enhancing tumor immunogenicity and mitigating immunosuppression is challenging and oft...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| 其他作者: | |
| 格式: | Article |
| 語言: | English |
| 出版: |
2024
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/181691 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Nanyang Technological University |
| 語言: | English |